A Phase 3 Randomised, Double-Masked, Placebo-Controlled Study of the Effect of OMS302 on Intraoperative Pupil Diameter in Subjects at High Risk of Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Ketorolac/phenylephrine (Primary)
- Indications Intraoperative complications; Iris diseases
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Omeros Corporation
- 14 Aug 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 27 Mar 2014 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT02093689)
- 03 Feb 2014 New trial record